Literature DB >> 8956208

Effect of nasal CPAP treatment on plasma volume, aldosterone and 24-h blood pressure in obstructive sleep apnoea.

S Saarelainen1, J Hasan, S Siitonen, E Seppälä.   

Abstract

Polycythaemia, peripheral oedema formation and hypertension have classically been described in association with obstructive sleep apnoea (OSA). However, there is very limited information about blood volume in OSA and how it changes during long-term treatment with nasal continuous positive airway pressure (nCPAP). Plasma (PV) and red-cell volumes (RCV), 24-h ambulatory blood pressure (BP), 24-h natriuresis and morning plasma aldosterone, renin activity and atrial natriuretic peptide in 11 men with a mean age of 47 y (range 37-55), apnoea index (AI) of 55 (22-106), body mass index of 36 (30-43) and seated BP of > or = 140/90 mmHg without any medication were measured. BP-measurements were repeated after 3 weeks and all measurements after 3 mo of nCPAP treatment. Aldosterone and 24-h mean heart rates decreased during treatment. Twenty-four-h BP decreased after 3 weeks but that decrease did not persist after 3 mo of treatment. There was a relationship between changes in night-time mean BP and PV and aldosterone. The haematocrit declined in every patient. No significant changes were found in the mean PV or RCV. They were in all instances lower than has earlier been described for normal, non-obese subjects. These data also suggest that OSA causes divergent individual disturbances in blood volume homeostasis which can be corrected by nCPAP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8956208     DOI: 10.1046/j.1365-2869.1996.t01-1-00007.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  16 in total

Review 1.  Coagulability in obstructive sleep apnea.

Authors:  Christina Liak; M Fitzpatrick
Journal:  Can Respir J       Date:  2011 Nov-Dec       Impact factor: 2.409

2.  Does continuous positive airway pressure reduce aldosterone levels in patients with obstructive sleep apnea?

Authors:  Si-Jiu Yang; Xing-Tang Jiang; Xiao-Bin Zhang; Xiao-Wen Yin; Wei-Xian Deng
Journal:  Sleep Breath       Date:  2016-01-15       Impact factor: 2.816

Review 3.  Sleep . 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension.

Authors:  G V Robinson; J R Stradling; R J O Davies
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

4.  Obstructive sleep apnea and aldosterone.

Authors:  Anna Svatikova; Lyle J Olson; Robert Wolk; Bradley G Phillips; Taro Adachi; Gary L Schwartz; Virend K Somers
Journal:  Sleep       Date:  2009-12       Impact factor: 5.849

5.  Effects of continuous positive airway pressure therapy on plasma aldosterone levels in patients with obstructive sleep apnea: A meta-analysis.

Authors:  Gang Deng; Zhan-Dong Qiu; Da-Yong Li; Yu Fang; Su-Ming Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

6.  Does obstructive sleep apnea increase hematocrit?

Authors:  Jong Bae Choi; José S Loredo; Daniel Norman; Paul J Mills; Sonia Ancoli-Israel; Michael G Ziegler; Joel E Dimsdale
Journal:  Sleep Breath       Date:  2006-09       Impact factor: 2.816

Review 7.  Obstructive sleep apnea syndrome: coagulation anomalies and treatment with continuous positive airway pressure.

Authors:  Domenico Maurizio Toraldo; Michele De Benedetto; Egeria Scoditti; Francesco De Nuccio
Journal:  Sleep Breath       Date:  2015-07-14       Impact factor: 2.816

Review 8.  Use of continuous positive airway pressure for sleep apnea in the treatment of hypertension.

Authors:  Matthew G Denker; Debbie L Cohen
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-09       Impact factor: 2.894

Review 9.  Associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea-what do we know so far?

Authors:  Huai Heng Loh; Norlela Sukor
Journal:  J Hum Hypertens       Date:  2019-12-10       Impact factor: 3.012

10.  Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea hypopnea syndrome: effect of continuous positive airway pressure treatment.

Authors:  Antonia Barceló; Javier Piérola; Cristina Esquinas; Mónica de la Peña; Meritxell Arqué; Alberto Alonso-Fernández; Josep Miquel Bauçà; Juan Robles; Bernardino Barceló; Ferran Barbé
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.